Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCNH5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100134937 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
MIR4656 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALOX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00965 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LIX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506165 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC339568 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELAVL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSGALNACT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728095 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB40AL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on